Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Invitae Corp (NVTA)
Invitae Corp (NVTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Is Invitae Stock a Buy Now?

Invitae shares have lost more than 80% over the past year and a half.

NVTA : 0.0195 (unch)
5 Cathie Wood Stocks Analysts Expect to Rally

These 5 stocks from the maverick investor's flagship ARKK fund have gained a vote of confidence from analysts, with Wall Street predicting significant upside potential from current levels.

NVDA : 673.61 (-3.01%)
TSLA : 194.17 (+0.21%)
U : 30.87 (-3.59%)
NVTA : 0.0195 (unch)
ACHR : 5.03 (-1.95%)
EXAS : 62.97 (+0.37%)
TTD : 81.74 (-0.99%)
SQ : 64.39 (-2.04%)
DKNG : 40.76 (-1.36%)
Better Growth Stock: CRISPR Therapeutics vs. Invitae

One of these stocks may be riskier than the other...

AAPL : 182.06 (+0.28%)
AMZN : 168.55 (+0.88%)
VRTX : 418.68 (-0.47%)
CRSP : 82.47 (+4.75%)
NVTA : 0.0195 (unch)
1 Cathie Wood Stock With Over 100% Upside, According to Analysts

This biotech stock under $10 is the newest addition to Cathie Wood's flagship ARKK fund - and Wall Street analysts have high hopes for the shares, too.

NVDA : 673.61 (-3.01%)
TSLA : 194.17 (+0.21%)
U : 30.87 (-3.59%)
NVTA : 0.0195 (unch)
ARKK : 47.26 (-2.94%)
$NASX : 15,525.19 (-0.68%)
RXRX : 12.35 (-1.91%)
Invitae (NVTA) Q3 2023 Earnings Call Transcript

NVTA earnings call for the period ending September 30, 2023.

NVTA : 0.0195 (unch)
Invitae: Q3 Earnings Snapshot

Invitae: Q3 Earnings Snapshot

NVTA : 0.0195 (unch)
3 Things About Invitae Every Smart Investor Knows

The last two years have been tumultuous, and there are no calm waters in sight.

NVTA : 0.0195 (unch)
Is Invitae Stock a Buy Now?

Invitae shares have dropped more than 60% this year.

NVTA : 0.0195 (unch)
Invitae Appoints Dr. David Sholehvar as Chief Operating Officer

/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the appointment of veteran healthcare leader David Sholehvar, M.D.,...

NVTA : 0.0195 (unch)
Rural Hospital System Demonstrates the Clinical Benefits of Implementing Universal Hereditary Cancer Testing in Patients with Breast Cancer

/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced results of its collaborative study on universal hereditary cancer...

NVTA : 0.0195 (unch)

Barchart Exclusives

Buy Disney Stock as the Magic Kingdom Makes a Comeback
It's no secret that Disney's traditional media empire is fading - but strategic moves into gaming and sports are a plus, not to mention exclusive rights to Taylor Swift's Eras Tour movie. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar